Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations

PLoS One. 2013 Sep 6;8(9):e73301. doi: 10.1371/journal.pone.0073301. eCollection 2013.

Abstract

The human gastric pathogen Helicobacter pylori forms biofilms in vitro and in vivo. The purpose of this study was to evaluate the effects of H. pylori biofilm formation in vitro on clarithromycin (CLR) susceptibility. CLR susceptibility of H. pylori intermediate (2-day) and mature (3-day) biofilms on glass coverslips was determined at concentrations from 0.03 to 0.5 µg/ml. H. pylori biofilm biomass was increased after treatment with CLR at minimum inhibitory concentration levels by up to 4-fold (2-day biofilm) and 16-fold (3-day biofilm). Minimum bactericidal concentrations of CLR against cells in a biofilm were higher (1.0 µg/ml) than that for planktonic cells (0.25 µg/ml). It was shown that the expression of efflux pump genes was significantly increased in biofilm cells. In addition, exposure of biofilms to CLR resulted in high level resistance generation compared to planktonic cells with increased resistance associated with the presence of a point mutation at either position 2142 or 2143 in the domain V loop of the 23S rRNA gene. These results demonstrate that H. pylori biofilm formation decreases the susceptibility to CLR and that H. pylori CLR resistance mutations are more frequently generated in biofilms than in planktonic cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Biofilms / drug effects*
  • Clarithromycin / pharmacology*
  • Drug Resistance, Bacterial
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / genetics
  • Helicobacter pylori / physiology*
  • Humans
  • Mutation
  • RNA, Ribosomal, 23S / genetics

Substances

  • Anti-Bacterial Agents
  • RNA, Ribosomal, 23S
  • Clarithromycin

Grants and funding

This work was supported in part by Grants for Scientific Research 23590518 and 24593166 from the Ministry of Education, Culture, Sport, Science and Technology, and a grant for Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2010–2014 (S1001024). This work was also partially supported by the Asahi Glass Foundation and Health and Labour Sciences Research Grants for Research on global health issues from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.